Immunohistochemistry - Revision history

Mikael Häggström: Size

2024-06-14T15:33:23Z

Size

← Older revision		Revision as of 11:33, 14 June 2024
Line 4:		Line 4:
	}}</noinclude>		}}</noinclude>
	[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]		[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
	[[File:Immunohistochemistry for p16 in uterine papillary serous adenocarcinoma showing both nuclear and cytoplasmic staining.jpg\|thumb\|~~240px~~\|"Block" staining: strong nuclear and cytoplasmic expression in a continuous segment of cells.<ref>Image by Mikael Häggström, MD. Reference for terminology: {{cite web\|url=https://www.pathologyoutlines.com/topic/stainsp16.html\|title=p16\|website=Pathology Outlines\|author=Anjelica Hodgson, M.D., Carlos Parra-Herran, M.D.}} Last staff update: 25 January 2024</ref>]]		[[File:Immunohistochemistry for p16 in uterine papillary serous adenocarcinoma showing both nuclear and cytoplasmic staining.jpg\|thumb\|160px\|'''"Block" staining''': strong nuclear and cytoplasmic expression in a continuous segment of cells.<ref>Image by Mikael Häggström, MD. Reference for terminology: {{cite web\|url=https://www.pathologyoutlines.com/topic/stainsp16.html\|title=p16\|website=Pathology Outlines\|author=Anjelica Hodgson, M.D., Carlos Parra-Herran, M.D.}} Last staff update: 25 January 2024</ref>]]
	When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.		When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.

Mikael Häggström: Size

2024-06-14T15:32:24Z

Size

← Older revision		Revision as of 11:32, 14 June 2024
Line 4:		Line 4:
	}}</noinclude>		}}</noinclude>
	[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]		[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
	[[File:Immunohistochemistry for p16 in uterine papillary serous adenocarcinoma showing both nuclear and cytoplasmic staining.jpg\|thumb\|"Block" staining: strong nuclear and cytoplasmic expression in a continuous segment of cells.<ref>Image by Mikael Häggström, MD. Reference for terminology: {{cite web\|url=https://www.pathologyoutlines.com/topic/stainsp16.html\|title=p16\|website=Pathology Outlines\|author=Anjelica Hodgson, M.D., Carlos Parra-Herran, M.D.}} Last staff update: 25 January 2024</ref>]]		[[File:Immunohistochemistry for p16 in uterine papillary serous adenocarcinoma showing both nuclear and cytoplasmic staining.jpg\|thumb\|240px\|"Block" staining: strong nuclear and cytoplasmic expression in a continuous segment of cells.<ref>Image by Mikael Häggström, MD. Reference for terminology: {{cite web\|url=https://www.pathologyoutlines.com/topic/stainsp16.html\|title=p16\|website=Pathology Outlines\|author=Anjelica Hodgson, M.D., Carlos Parra-Herran, M.D.}} Last staff update: 25 January 2024</ref>]]
	When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.		When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.

Mikael Häggström: +Block

2024-06-14T15:31:51Z

+Block

← Older revision		Revision as of 11:31, 14 June 2024
Line 4:		Line 4:
	}}</noinclude>		}}</noinclude>
	[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]		[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
			[[File:Immunohistochemistry for p16 in uterine papillary serous adenocarcinoma showing both nuclear and cytoplasmic staining.jpg\|thumb\|"Block" staining: strong nuclear and cytoplasmic expression in a continuous segment of cells.<ref>Image by Mikael Häggström, MD. Reference for terminology: {{cite web\|url=https://www.pathologyoutlines.com/topic/stainsp16.html\|title=p16\|website=Pathology Outlines\|author=Anjelica Hodgson, M.D., Carlos Parra-Herran, M.D.}} Last staff update: 25 January 2024</ref>]]
	When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.		When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.

Mikael Häggström: /* Evaluation */ +COntrols

2024-06-13T19:55:44Z

Evaluation: +COntrols

← Older revision		Revision as of 15:55, 13 June 2024
Line 99:		Line 99:

	==Evaluation==		==Evaluation==
			[[File:Positive and negative controls in immunohistochemistry.png\|thumb\|270px\|Confirm that you see the expected results for positive and negative controls. For this purpose, "internal" means tissue from the target patient, and "external" means that the tissue is from another patient.<ref>Image by Mikael Häggström, MD. Reference: {{cite journal\| author=Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M \| display-authors=etal\| title=Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel. \| journal=Appl Immunohistochem Mol Morphol \| year= 2014 \| volume= 22 \| issue= 4 \| pages= 241-52 \| pmid=24714041 \| doi=10.1097/PAI.0000000000000069 \| pmc=4206554 \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24714041 }}</ref>]]
	First be familiar with which cells on the slide are being evaluated, such as first looking at a slide with standard staining (usually H&E) to avoid counting background cells.		First be familiar with which cells on the slide are being evaluated, such as first looking at a slide with standard staining (usually H&E) to avoid counting background cells.

Mikael Häggström: /* Immunohistochemistry ordering */ Local routines

2024-01-03T17:22:42Z

Immunohistochemistry ordering: Local routines

← Older revision		Revision as of 13:22, 3 January 2024
Line 9:		Line 9:
	The main approaches to immunohistochemistry ordering are:		The main approaches to immunohistochemistry ordering are:
	*If there is '''insufficient tissue''' left for immunohistochemistry after standard (usually H&E) staining, you can potentially ask a histotechnologist to destain a glass slide and subsequently perform IHC on that slide. For small specimens, if you predict that there will be several stainsin the near future, order extra unstained slides upfront (since there is always a bit of a waste of tissue at the microtome if the paraffin block needs to be remounted and cut later).		*If there is '''insufficient tissue''' left for immunohistochemistry after standard (usually H&E) staining, you can potentially ask a histotechnologist to destain a glass slide and subsequently perform IHC on that slide. For small specimens, if you predict that there will be several stainsin the near future, order extra unstained slides upfront (since there is always a bit of a waste of tissue at the microtome if the paraffin block needs to be remounted and cut later).
	*Look for a specified '''panel''' for the presentation at hand. For example, for an undifferentiated tumor with no clear lineage differentiation, an initial panel of cytokeratin (CK), S100, vimentin and LCA (CD45) can be used.<ref name="pmid25427040">{{cite journal\| author=Lin F, Liu H\| title=Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. \| journal=Arch Pathol Lab Med \| year= 2014 \| volume= 138 \| issue= 12 \| pages= 1583-610 \| pmid=25427040 \| doi=10.5858/arpa.2014-0061-RA \| pmc= \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25427040 }} </ref>		*Look for a specified '''panel''' for the presentation at hand. For example, for an undifferentiated tumor with no clear lineage differentiation, an initial panel of cytokeratin (CK), S100, vimentin and LCA (CD45) can be used.<ref name="pmid25427040">{{cite journal\| author=Lin F, Liu H\| title=Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. \| journal=Arch Pathol Lab Med \| year= 2014 \| volume= 138 \| issue= 12 \| pages= 1583-610 \| pmid=25427040 \| doi=10.5858/arpa.2014-0061-RA \| pmc= \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25427040 }} </ref> {{further\|Tumor evaluation}}<br>In cancer cases, also be familiar with local routines for reflex tests by various cancer types, which may include both immunohistochemistry and other molecular tests.
	*Coming up with the most relevant '''differential diagnoses''' for the case at hand, and find the immunohistochemistry stains that best distinguish them. Immunohistochemistry profiles for diseases and conditions, as well as their main differential diagnoses, is generally found at '''[https://www.pathologyoutlines.com/ Pathology Outlines]''', or you can pay for a subscription to '''[https://www.immunoquery.com/ ImmunoQuery]'''{{ImmunoQuery COI declaration}}:		*Coming up with the most relevant '''differential diagnoses''' for the case at hand, and find the immunohistochemistry stains that best distinguish them. Immunohistochemistry profiles for diseases and conditions, as well as their main differential diagnoses, is generally found at '''[https://www.pathologyoutlines.com/ Pathology Outlines]''', or you can pay for a subscription to '''[https://www.immunoquery.com/ ImmunoQuery]'''{{ImmunoQuery COI declaration}}:

Mikael Häggström: /* Evaluation */ +Depending on parts

2023-12-08T23:06:31Z

Evaluation: +Depending on parts

← Older revision		Revision as of 19:06, 8 December 2023
Line 100:		Line 100:
	==Evaluation==		==Evaluation==
	First be familiar with which cells on the slide are being evaluated, such as first looking at a slide with standard staining (usually H&E) to avoid counting background cells.		First be familiar with which cells on the slide are being evaluated, such as first looking at a slide with standard staining (usually H&E) to avoid counting background cells.

			When the relevant cells take up stains, confirm whether their staining pattern actually counts as positive. For example, a cytoplasmic staining for p63 still counts as "negative (cytoplasmic)" when suspecting squamous, myoepithelial and prostatic basal cells (where only nuclear stain counts as positive). On the other hand, the same cytoplasmic staining for p63 counts as "positive (cytoplasmic)" when suspecting muscle differentiation.<ref name="pmid21623385">{{cite journal\| author=Martin SE, Temm CJ, Goheen MP, Ulbright TM, Hattab EM\| title=Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: an immunohistochemical and immunoelectron microscopic study. \| journal=Mod Pathol \| year= 2011 \| volume= 24 \| issue= 10 \| pages= 1320-6 \| pmid=21623385 \| doi=10.1038/modpathol.2011.89 \| pmc= \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21623385 }} </ref>

	==Interpretation==		==Interpretation==

Mikael Häggström: /* Immunohistochemistry ordering */ Upfront

2023-11-06T17:01:01Z

Immunohistochemistry ordering: Upfront

← Older revision		Revision as of 13:01, 6 November 2023
Line 8:		Line 8:
	==Immunohistochemistry ordering==		==Immunohistochemistry ordering==
	The main approaches to immunohistochemistry ordering are:		The main approaches to immunohistochemistry ordering are:
	*If there is '''insufficient tissue''' left for immunohistochemistry after standard (usually H&E) staining, you can potentially ask a histotechnologist to destain a glass slide and subsequently perform IHC on that slide.		*If there is '''insufficient tissue''' left for immunohistochemistry after standard (usually H&E) staining, you can potentially ask a histotechnologist to destain a glass slide and subsequently perform IHC on that slide. For small specimens, if you predict that there will be several stainsin the near future, order extra unstained slides upfront (since there is always a bit of a waste of tissue at the microtome if the paraffin block needs to be remounted and cut later).
	*Look for a specified '''panel''' for the presentation at hand. For example, for an undifferentiated tumor with no clear lineage differentiation, an initial panel of cytokeratin (CK), S100, vimentin and LCA (CD45) can be used.<ref name="pmid25427040">{{cite journal\| author=Lin F, Liu H\| title=Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. \| journal=Arch Pathol Lab Med \| year= 2014 \| volume= 138 \| issue= 12 \| pages= 1583-610 \| pmid=25427040 \| doi=10.5858/arpa.2014-0061-RA \| pmc= \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25427040 }} </ref>		*Look for a specified '''panel''' for the presentation at hand. For example, for an undifferentiated tumor with no clear lineage differentiation, an initial panel of cytokeratin (CK), S100, vimentin and LCA (CD45) can be used.<ref name="pmid25427040">{{cite journal\| author=Lin F, Liu H\| title=Immunohistochemistry in undifferentiated neoplasm/tumor of uncertain origin. \| journal=Arch Pathol Lab Med \| year= 2014 \| volume= 138 \| issue= 12 \| pages= 1583-610 \| pmid=25427040 \| doi=10.5858/arpa.2014-0061-RA \| pmc= \| url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25427040 }} </ref>
	*Coming up with the most relevant '''differential diagnoses''' for the case at hand, and find the immunohistochemistry stains that best distinguish them. Immunohistochemistry profiles for diseases and conditions, as well as their main differential diagnoses, is generally found at '''[https://www.pathologyoutlines.com/ Pathology Outlines]''', or you can pay for a subscription to '''[https://www.immunoquery.com/ ImmunoQuery]'''{{ImmunoQuery COI declaration}}:		*Coming up with the most relevant '''differential diagnoses''' for the case at hand, and find the immunohistochemistry stains that best distinguish them. Immunohistochemistry profiles for diseases and conditions, as well as their main differential diagnoses, is generally found at '''[https://www.pathologyoutlines.com/ Pathology Outlines]''', or you can pay for a subscription to '''[https://www.immunoquery.com/ ImmunoQuery]'''{{ImmunoQuery COI declaration}}:

Mikael Häggström:

2022-11-29T00:40:55Z

← Older revision		Revision as of 20:40, 28 November 2022
Line 1:		Line 1:
	{{Top		<noinclude>{{Top
	\|author1=[[User:Mikael Häggström\|Mikael Häggström]]		\|author1=[[User:Mikael Häggström\|Mikael Häggström]]
	\|author2=		\|author2=
	}}		}}</noinclude>
	[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]		[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
	When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.		When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.

Mikael Häggström: Moved

2022-10-05T21:08:26Z

Moved

← Older revision		Revision as of 17:08, 5 October 2022
Line 3:		Line 3:
	\|author2=		\|author2=
	}}		}}
			[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
	When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.		When [[learning pathology]], the percentages by which immunohistochemistry (IHC) results are positive or negative for various diseases are generally easily looked up when needed, so what a pathologist needs to learn is mainly '''how to select''' the optimal immunohistochemistry panels in the first place for various presentations where the diagnosis is unknown.

Line 101:		Line 102:

	==Interpretation==		==Interpretation==
	~~[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]~~
	The main methods for interpreting immunohistochemistry results are:		The main methods for interpreting immunohistochemistry results are:
	*Looking up each differential diagnosis at for example '''[https://www.pathologyoutlines.com/ Pathology Outlines]''' and comparing their expected staining to see which entity is most likely.		*Looking up each differential diagnosis at for example '''[https://www.pathologyoutlines.com/ Pathology Outlines]''' and comparing their expected staining to see which entity is most likely.

Mikael Häggström: /* Interpretation */ Expanded

2022-10-05T21:06:32Z

Interpretation: Expanded

← Older revision		Revision as of 17:06, 5 October 2022
Line 101:		Line 101:

	==Interpretation==		==Interpretation==
	[[File:~~Immunohistochemistry of cytoplasmic versus nuclear~~ staining.jpg\|thumb\|~~230px~~\|Main staining patterns.]]		[[File:Main staining patterns on immunohistochemistry.jpg\|thumb\|270px\|Main staining patterns.]]
	The main methods for interpreting immunohistochemistry results are:		The main methods for interpreting immunohistochemistry results are:
	*Looking up each differential diagnosis at for example '''[https://www.pathologyoutlines.com/ Pathology Outlines]''' and comparing their expected staining to see which entity is most likely.		*Looking up each differential diagnosis at for example '''[https://www.pathologyoutlines.com/ Pathology Outlines]''' and comparing their expected staining to see which entity is most likely.